Physician profile
Joseph Rizzo
NPI 1104829639
$3,286.76
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,891 · 2020: $1,150 · 2021: $69.04 · 2022: $56.96 · 2023: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $119.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $589.31 | 2019-2022 | |
| Amgen INC. | $539.49 | 2019-2020 | |
| Medtronic Vascular, INC. | $456.69 | 2019-2020 | |
| Amarin Pharma, INC. | $348.83 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $291.46 | 2019 | |
| Edwards Lifesciences Corporation | $269.61 | 2020 | |
| Medtronic, INC. | $131.97 | 2022-2023 | Corevalve Evolut R |
| Janssen Pharmaceuticals, INC | $127.67 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.06 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $66.01 | 2019-2020 | |
| Cardinal Health 200 LLC | $65.87 | 2019 | |
| Sanofi-Aventis U.S. LLC | $61.37 | 2019 | |
| Abbott Laboratories | $58.71 | 2020-2021 | |
| Gilead Sciences, INC. | $41.32 | 2019 | |
| Pfizer INC. | $40.66 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $39.90 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $18.63 | 2019 | |
| Novo Nordisk INC | $16.26 | 2021 | |
| Alnylam Pharmaceuticals INC. | $15.91 | 2019 | |
| W. L. Gore & Associates, INC. | $15.48 | 2020 | |
| Tactile Systems Technology INC | $13.42 | 2019 | |
| Bardy Diagnostics, INC. | $6.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Rizzo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.